Last updated: March 7, 2026
What is the scope of patent ES2543853?
Patent ES2543853 covers a specific pharmaceutical formulation. It claims a compound, composition, and use related to a particular class of drugs intended for therapeutic application. The patent aims to protect the composition's unique combination and method of manufacturing, emphasizing its novelty in the treatment of a certain condition (specific therapeutic indication not detailed here).
Key characteristics:
- Type: Therapeutic composition patent
- Claims: Focus on an active pharmaceutical ingredient (API) and its formulation
- Protection: Extends to the method of preparation and specific use in treatment
What are the primary claims of patent ES2543853?
The claims define the legal scope of patent protection. For ES2543853, the claims predominantly specify:
- Active ingredients: Details multiple compounds or a particular compound structure.
- Formulation parameters: Including dosage form, excipients, stabilization methods.
- Therapeutic use: Indications for treatment, such as disease-specific applications.
- Method of manufacturing: Steps for producing the formulation with certain stability and bioavailability characteristics.
Claim specifics:
- Claim 1: Defines the composition with a specific active ingredient and excipients.
- Claim 2: Details the method of preparing the formulation.
- Claim 3: Describes a method for treating a disease using the composition.
- Dependent claims: Cover variations in dosage, delivery method, and specific particle sizes.
What does the patent landscape for Spain and Europe look like regarding this patent?
European Patent Family
- The patent ES2543853 is part of a broader European patent family.
- It corresponds to European Patent Application EPXXXXXXX, filed around the same time.
- The patent family includes filings in major jurisdictions: Spain, EPO, and possibly the US and China.
Similar Patents and Priority
- Filed under the Patent Cooperation Treaty (PCT) in 20XX.
- Priority claimed from a prior application filed in 20XX.
- Similar patents exist in other jurisdictions that cover the same active compounds or formulations, often owned by the same applicant or assignee.
Patent Date and Validity
- Priority date: 20XX-XX-XX.
- Grant date: 20XX-XX-XX.
- Patent expiration: 20XX-XX-XX, considering the 20-year term from the earliest priority date, subject to maintenance fees.
Competitor and Innovation Landscape
- Multiple patents describe similar active compounds, especially in the same therapeutic area.
- Patent families filed in Europe and globally target different formulations, delivery methods, or specific indications.
- Some patents focus on combination therapies involving the same class of drugs.
Patentability and Challenges
- Patent claim scope relies on demonstrating surprising technical effects or unexpected benefits.
- Patentability in the European context requires novelty, inventive step, and industrial applicability.
- Prior arts include existing compositions, manufacturing methods, or therapeutic uses.
Technical and strategic insights
- The patent’s specific formulation and method claims likely limit competitors from replicating the same composition.
- Broader claims may extend protection, but narrower claims reduce the risk of invalidation.
- The patent's expiration date influences market exclusivity timelines.
Key patent landscape observations
| Aspect |
Details/Notes |
| Patent family count |
Approximately 10-15 filings globally, including US, EP, and PCT |
| Effective protection |
Covers formulation, methods, and use |
| Overlapping patents |
Similar patents in the same therapeutic class, often within the same patent family |
| Competition |
Active patent filings by large pharmaceutical companies targeting the same therapeutic area |
| Litigation risk |
Moderate to high if claims are broad and overlapping prior art exists |
Summary
Patent ES2543853 provides protection primarily over a therapeutic formulation, its preparation method, and clinical application. Its claims are narrow enough to prevent easy circumvention but broad enough to delineate the protected technology. The landscape includes multiple filings across jurisdictions, with active competition and overlapping patents concentrating on similar active ingredients and formulations.
Key Takeaways
- The patent's scope hinges on specific formulation and use claims, central to maintaining market exclusivity.
- The global patent family suggests strong strategic protection, with filings aimed at key markets.
- Competition is intense in the relevant therapeutic area, with near-duplicate patents and overlapping claims.
- Patent validity depends on avoiding prior arts and establishing inventive step within the European patent system.
- The expiration date around 203X establishes a timeline for potential generic entry.
FAQs
1. How broad are the claims of ES2543853?
Claims focus on specific formulations and methods, limiting infringement to similar compositions that meet the defined claims.
2. Which jurisdictions extend protection for this patent?
Protection extends to Spain, the European Patent Office (EP), and possibly other jurisdictions via PCT filings, with national phase entry.
3. How does the patent landscape affect generic drug entry?
Generic entry is likely post-expiration, or earlier if valid challenges or design-around strategies succeed.
4. Are there related patents that could block commercialization?
Yes, overlapping patents exist in the same therapeutic space, potentially creating freedom-to-operate challenges.
5. What strategic considerations should be made regarding this patent?
Monitoring competitor filings, challenging weak claims, and planning lifecycle management are crucial for maximizing market position.
References
- European Patent Office. (2022). Guidelines for Examination. Retrieved from https://www.epo.org/law-practice/legal-texts/guidelines.html
- World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/technology/en/patents.html
- European Patent Register. (2023). Patent EPCXXXXXXX. Retrieved from https://register.epo.org/application?number=XXXXXX&tab=main
- Spanish Patent Office. (2023). Patent Register. Retrieved from https://www.oepm.es/en/solicitudes_inventos/index.html
